Home › Compare › NGMDF vs MRK

NGMDF vs MRK: Dividend Comparison 2026

NGMDF yields 11049.72% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NGMDF wins by $147553567626435040.00M in total portfolio value
10 years
NGMDF
NGMDF
● Live price
11049.72%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$147553567626435040.00M
Annual income
$144,972,659,984,467,210,000,000.00
Full NGMDF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — NGMDF vs MRK

📍 NGMDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNGMDFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NGMDF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NGMDF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NGMDF
Annual income on $10K today (after 15% tax)
$939,226.52/yr
After 10yr DRIP, annual income (after tax)
$123,226,760,986,797,130,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, NGMDF beats the other by $123,226,760,986,797,130,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NGMDF + MRK for your $10,000?

NGMDF: 50%MRK: 50%
100% MRK50/50100% NGMDF
Portfolio after 10yr
$73776783813217520.00M
Annual income
$72,486,329,992,233,605,000,000.00/yr
Blended yield
98.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NGMDF
No analyst data
Altman Z
-3.9
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NGMDF buys
0
MRK buys
0
No recent congressional trades found for NGMDF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNGMDFMRK
Forward yield11049.72% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$147553567626435040.00M ✓$30.7K
Annual income after 10y$144,972,659,984,467,210,000,000.00 ✓$950.29
Total dividends collected$147382103252220128.00M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NGMDF vs MRK ($10,000, DRIP)

YearNGMDF PortfolioNGMDF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,115,672$1,104,972.38$11,192$351.54+$1.10M → NGMDF
2$116,407,522$115,213,752.85$12,524$392.70+$116.39M → NGMDF
3$11,359,344,803$11,234,788,754.61$14,015$438.65+$11359.33M → NGMDF
4$1,036,752,183,573$1,024,597,684,633.76$15,682$489.96+$1036752.17M → NGMDF
5$88,505,267,038,414$87,395,942,201,990.16$17,547$547.23+$88505267.02M → NGMDF
6$7,067,411,377,156,568$6,972,710,741,425,466.00$19,632$611.16+$7067411377.14M → NGMDF
7$527,928,385,828,875,460$520,366,255,655,317,900.00$21,963$682.53+$527928385828.85M → NGMDF
8$36,892,758,069,906,610,000$36,327,874,697,069,710,000.00$24,571$762.18+$36892758069906.59M → NGMDF
9$2,412,063,216,792,362,000,000$2,372,587,965,657,561,700,000.00$27,486$851.08+$2412063216792362.00M → NGMDF
10$147,553,567,626,435,030,000,000$144,972,659,984,467,210,000,000.00$30,745$950.29+$147553567626435040.00M → NGMDF

NGMDF vs MRK: Complete Analysis 2026

NGMDF — Stock

NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventional/pediatric vaccines. The company was formerly known as BuzBuz Capital Corp. NuGen Medical Devices Inc. is based in Toronto, Canada.

Full NGMDF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this NGMDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NGMDF vs SCHDNGMDF vs JEPINGMDF vs ONGMDF vs KONGMDF vs MAINNGMDF vs JNJNGMDF vs ABBVNGMDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.